Navigation Links
NeoStem Announces Participation in Multiple September Conferences
Date:9/8/2011

NEW YORK, Sept. 8, 2011 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced it is presenting at three upcoming September conferences: the Rodman & Renshaw Annual Healthcare Conference, the Cell Therapy Commercialization Summit, and the JMP Securities Healthcare Conference.

"NeoStem's strategic combination of revenues with manufacturing and a global reach has positioned the Company to be a leader in the cell therapy space and we are pleased to share NeoStem updates with industry and the investor community," said Dr. Robin L. Smith, Chairman and CEO of NeoStem.  NeoStem will be presenting at the following conferences:

Rodman & Renshaw 13th Annual Healthcare Conference - September 11-13, New York, New York

11:15 AM on Monday, September 12 at the Waldorf Astoria, New York, NY in the Starlight North room.

Cell Therapy Commercialization Summit - September 19-21, Boston, MA

11 AM on Monday, September 19 as part of the Cell Therapy Investor Forum, located in the Seaport World Trade Center.

1:45 PM and 4:30 PM on Tuesday, September 20.

6th Annual JMP Securities Healthcare Conference - September 27-29, New York, New York

Wednesday, September 28 at 9 AM at the St. Regis Hotel, New York, NY.

About NeoStem, Inc.

NeoStem is engaged in the development and manufacturing of cell-based therapies in the U.S. Its January, 2011 acquisition of Progenitor Cell Therapy, and its July 13, 2011 agreement to acquire Amorcyte, Inc. (which is expected to close in the fourth quarter subject to shareholder approval) position NeoStem to achieve its mission of capturing the paradigm shift to cell therapy.


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeoStem Appoints Grant Thornton LLP as New Independent Registered Public Accounting Firm
2. NeoStem Provides Update on Amorcyte Clinical Progress and Reports Results for Second Quarter
3. NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
4. NeoStem Announces Proposed Public Offering of Common Stock
5. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
6. NeoStem Announces Agreement with Nankai Hospital in Tianjin to Offer NeoStems Licensed Orthopedic Technology
7. NeoStems Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
8. NeoStems Subsidiary Progenitor Cell Therapy Receives FACT Accreditation for Its New Allendale, New Jersey Manufacturing Facility
9. NeoStem to Present at 10th Annual Needham Healthcare Conference on Tuesday, April 5
10. NeoStem Provides Results for 2010 and an Update on Recent Activities
11. NeoStem To Present at Rodman & Renshaw Annual China Investment Conference on Tuesday, March 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 28, 2015 CTI BioPharma ... plans to report its second quarter 2015 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
(Date:7/27/2015)... PARIS , July 28, 2015   ... entered into a new global collaboration to discover, develop ... field of immuno-oncology. As part of the agreement, the ... protein 1 (PD-1) inhibitor currently in Phase 1 testing ... new therapeutic candidates based on ongoing, innovative preclinical programs. ...
(Date:7/27/2015)... WESTLAKE VILLAGE, Calif. , July 27, ... and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today ... granted early termination of the waiting period under the ... respect to Allergan,s pending acquisition of KYTHERA.  ... July 6, 2015, each of Allergan and KYTHERA filed ...
Breaking Medicine Technology:CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, the US ... counseling for persons who are obese and those who are overweight with at least ... mandate will affect any commercial health plan with a program year start after August ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk factors, ... brain volumes that may be early indicators of Alzheimer’s disease and dementia, according ... that vascular risk factors damage the brain and can result in cognitive impairment,” ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National ... a 2015 Professional Woman of the Year. Ms. Baum-Lappe is recognized with this ... professional women in the country, spanning virtually every industry and profession, the National ...
(Date:7/27/2015)... ... July 27, 2015 , ... The FSH Society ... incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced the introduction of the first-ever ... care guideline is published today. , This new guideline condenses the results ...
(Date:7/27/2015)... ... July 27, 2015 , ... Eugene Batelli, D.P.M., F.A.C.F.A.S, just recently ... “The patient is high-end athlete, whose accomplishments include running in 27 triathlons and swimming ... pain, which was diagnosed as tendinitis. I did an ultrasound and found a ...
Breaking Medicine News(10 mins):Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 3
... AMDL, Inc. (NYSE Alternext US: ADL) , a ... its Chairman and CEO Mr. Douglas MacLellan has appeared ... 4, 2009 at 6:40 a.m. ET (3:40 a.m. PT). ... Fox Business News to discuss the Chinese business environment ...
... to Advance Understanding and Treatment of Pulmonary Fibrosis ... for Pulmonary Fibrosis (CPF) and the American Thoracic ... pulmonary, critical care and sleep physicians, today announced ... University Medical Center (Columbus, OH) and Harikrishna ...
... to share their heart-healthy lifestyle choicesDALLAS, Feb. 4 ... while others are life changing. Heart disease is the ... research shows that eighty percent of cardiac events in ... choices for their hearts, involving diet, exercise and abstinence ...
... Invisicare to ChinaLAS VEGAS and PLAINSBORO, N.J., Feb. 4 ... the developers of Invisicare , a ... for topical products, and RHEI Pharmaceuticals NV, a Belgium ... China, today announced they have signed a first option ...
... (Nasdaq: CADX ), a biopharmaceutical company focused ... for use in the hospital setting, announced today that ... the company,s corporate overview on Tuesday, February 10, 2009 ... BIO CEO and Investor Conference at the Waldorf Astoria ...
... Several big names in professional football and television ... 28 for the Third Annual National Walk for Epilepsy. ... Alan Faneca, and Atlanta Falcons running back Jason Snelling, ... their own teams of friends, relatives and fans. Together ...
Cached Medicine News:Health News:AMDL Inc.'s Chairman & CEO Mr. Douglas MacLellan Featured on FOX Business News Wednesday, February 4, 2009 2Health News:AMDL Inc.'s Chairman & CEO Mr. Douglas MacLellan Featured on FOX Business News Wednesday, February 4, 2009 3Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 2Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 3Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 4Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 2Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 3Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 4Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 2Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 3Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 4Health News:Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C. 2Health News:Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C. 3
... The Transfusion Safety Management system ensures your ... and care. , BloodTrack SafeTx uses the ... patient from sample collection to transfusion. SafeTx ... and reduces the need for bedside paperwork ...
... wCareCollect™ improves the specimen collection process. A ... information on the handheld at the bedside. ... the specific patient. Collection status information can ... which can reduce redraws, enhancing patient comfort, ...
... System is a custom-designed nursing ... safety while improving overall efficiency. ... managing a myriad of tasks ... linked real-time to the hospitals ...
Med Administration Check closes the loop on the medication use process by automatically validating and documenting medication administration....
Medicine Products: